These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 37775345)

  • 1. Evaluation of Cangrelor Use After Percutaneous Coronary Intervention in Patients With Mechanical Circulatory Support.
    Pluenneke JC; Mohamed AM; Hayes CH; Berry TP; Thomas EL; Zhurav L; Kozinn JB; Haines MM; Welge JA
    J Cardiothorac Vasc Anesth; 2023 Dec; 37(12):2511-2516. PubMed ID: 37775345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antithrombotic Stewardship: Evaluation of Platelet Reactivity-Guided Cangrelor Dosing Using the VerifyNow Assay.
    Connery A; Ahuja T; Katz A; Arnouk S; Zhu E; Papadopoulos J; Rao S; Merchan C
    J Cardiovasc Pharmacol; 2024 May; 83(5):482-489. PubMed ID: 38335531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiplatelet Therapy Bridging With Cangrelor in Patients With Coronary Stents: A Case Series.
    Bowman S; Gass J; Weeks P
    Ann Pharmacother; 2019 Feb; 53(2):171-177. PubMed ID: 30132336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Use of Cangrelor After Percutaneous Coronary Intervention in Patients Requiring Mechanical Circulatory Support.
    Katz A; Lewis TC; Arnouk S; Altshuler D; Papadopoulos J; Toy B; Smith DE; Merchan C
    Ann Pharmacother; 2021 Oct; 55(10):1215-1222. PubMed ID: 33567855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of Outcomes in Patients Requiring Mechanical Circulatory Support Who Received Cangrelor in Addition to Anticoagulation Versus Anticoagulation Alone.
    Martin TC; Duewell BE; Juul JJ; Rinka JRG; Rein L; Feih JT
    J Cardiothorac Vasc Anesth; 2024 Jun; 38(6):1328-1336. PubMed ID: 38521630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel use of cangrelor in pediatrics: A pilot cohort study demonstrating use in ventricular assist devices.
    Fahnhorst SE; Beasley G; Goldberg JF; Martinez HR; Ryan KA; Towbin JA; Boston U; Absi M
    Artif Organs; 2021 Jan; 45(1):38-45. PubMed ID: 33180355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet Inhibition With Cangrelor and Crushed Ticagrelor in Patients With ST-Segment-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.
    Franchi F; Rollini F; Rivas A; Wali M; Briceno M; Agarwal M; Shaikh Z; Nawaz A; Silva G; Been L; Smairat R; Kaufman M; Pineda AM; Suryadevara S; Soffer D; Zenni MM; Bass TA; Angiolillo DJ
    Circulation; 2019 Apr; 139(14):1661-1670. PubMed ID: 30630341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Cerebrovascular Events Older Than One Year on Ischemic and Bleeding Outcomes With Cangrelor in Percutaneous Coronary Intervention.
    Sawlani NN; Harrington RA; Stone GW; Steg PG; Gibson CM; Hamm CW; Price MJ; Prats J; Deliargyris EN; Mahaffey KW; White HD; Bhatt DL
    Circ Cardiovasc Interv; 2017 Jan; 10(1):. PubMed ID: 28039321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet Function Testing to Guide Cangrelor Dosing in Patients with Temporary Mechanical Circulatory Support or as a Bridge to Procedure.
    Buck MM; Barry CI; Montepara CA; Verlinden NJ
    Clin Appl Thromb Hemost; 2024; 30():10760296241237228. PubMed ID: 38439661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and Safety of Cangrelor in Preventing Periprocedural Complications in Patients With Stable Angina and Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention: The CHAMPION PHOENIX Trial.
    Abtan J; Steg PG; Stone GW; Mahaffey KW; Gibson CM; Hamm CW; Price MJ; Abnousi F; Prats J; Deliargyris EN; White HD; Harrington RA; Bhatt DL;
    JACC Cardiovasc Interv; 2016 Sep; 9(18):1905-13. PubMed ID: 27659566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of cangrelor and access site on ischaemic and bleeding events: insights from CHAMPION PHOENIX.
    Gutierrez JA; Harrington RA; Blankenship JC; Stone GW; Steg PG; Gibson CM; Hamm CW; Price MJ; Généreux P; Prats J; Deliargyris EN; Mahaffey KW; White HD; Bhatt DL;
    Eur Heart J; 2016 Apr; 37(14):1122-30. PubMed ID: 26400827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cangrelor vs. glycoprotein IIb/IIIa inhibitors during percutaneous coronary intervention.
    Yerasi C; Case BC; Chezar-Azerrad C; Forrestal BJ; Medranda GA; Shea C; Zhang C; Ben-Dor I; Satler LF; Bernardo NL; Hashim H; Garcia-Garcia HM; Waksman R
    Am Heart J; 2021 Aug; 238():59-65. PubMed ID: 33961829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of Ischemic and Bleeding Risks Associated With 2 Parenteral Antiplatelet Strategies Comparing Cangrelor With Glycoprotein IIb/IIIa Inhibitors: An Exploratory Analysis From the CHAMPION Trials.
    Vaduganathan M; Harrington RA; Stone GW; Deliargyris EN; Steg PG; Gibson CM; Hamm CW; Price MJ; Menozzi A; Prats J; Elkin S; Mahaffey KW; White HD; Bhatt DL
    JAMA Cardiol; 2017 Feb; 2(2):127-135. PubMed ID: 27902833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of cangrelor in patients with acute coronary syndromes undergoing percutaneous coronary intervention: Study design and interim analysis of the ARCANGELO study.
    De Luca L; Calabrò P; Chirillo F; Rolfo C; Menozzi A; Capranzano P; Menichelli M; Nicolini E; Mauro C; Trani C; Versaci F; Tomai F; Musumeci G; Di Mario C; Pepe M; Berti S; Cernetti C; Cirillo P; Maffeo D; Talanas G; Ferlini M; Contarini M; Lanzilotti V; Scherillo M; Tarantini G; Muraglia S; Rossini R; Bolognese L;
    Clin Cardiol; 2022 Sep; 45(9):913-920. PubMed ID: 35733352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cangrelor in cardiogenic shock and after cardiopulmonary resuscitation: A global, multicenter, matched pair analysis with oral P2Y
    Droppa M; Vaduganathan M; Venkateswaran RV; Singh A; Szumita PM; Roberts RJ; Qamar A; Hack L; Rath D; Gawaz M; Fuernau G; de Waha-Thiele S; Desch S; Schneider S; Ouarrak T; Jaffer FA; Zeymer U; Thiele H; Bhatt DL; Geisler T
    Resuscitation; 2019 Apr; 137():205-212. PubMed ID: 30790690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Platelet Inhibition by Cangrelor Among Obese Patients Undergoing Coronary Stenting: Insights From CHAMPION.
    Peterson BE; Harrington RA; Stone GW; Steg PG; Gibson CM; Hamm CW; Price MJ; Lopes RD; Leonardi S; Prats J; Deliargyris EN; Mahaffey KW; White HD; Bhatt DL
    Circ Cardiovasc Interv; 2022 Mar; 15(3):e011069. PubMed ID: 35196863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and Efficacy of Cangrelor in Acute Coronary Syndromes: A Systematic Review and Network Meta-Analysis.
    Mostafa MR; Eid MM; Awad AK; Takla A; Hassan AR; Katamesh BE; AlBarakat MM; Ziada AR; Mohamed S; Al-Azizi KM; Goldsweig AM
    Am J Cardiovasc Drugs; 2024 Jan; 24(1):71-81. PubMed ID: 37995040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cangrelor - Expanding therapeutic options in patients with acute coronary syndrome.
    Kubica J; Adamski P; Dobrzycki S; Gajda R; Gąsior M; Gierlotka M; Jaguszewski M; Legutko J; Lesiak M; Navarese EP; Niezgoda P; Ostrowska M; Pawłowski T; Tycińska A; Umińska JM; Witkowski A; Gil R
    Cardiol J; 2024; 31(1):133-146. PubMed ID: 37964649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of clinical outcomes with cangrelor plus aspirin versus oral dual antiplatelet therapy in patients supported with venoarterial extracorporeal membrane oxygenation.
    Cohan D; Uricchio MN; Konopka CI; Montepara CA; Verlinden NJ
    Artif Organs; 2023 Oct; 47(10):1672-1677. PubMed ID: 37203212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Use of Cangrelor in Cardiogenic Shock: Insights from the CAMEO Registry.
    Rymer J; Pichan C; Page C; Alhanti B; Bhatt DL; Kochar A; Angiolillo DJ; Diaz M; Wimmer NJ; Waksman R; Ang L; Bach R; Jenkins R; El-Sabae H; Brothers L; Ohman EM; Jones WS; Washam JB; Wang TY; Narcisse D; Basir MB
    J Card Fail; 2024 Oct; 30(10):1233-1240. PubMed ID: 39389732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.